SpaceX Has Filed Confidentially For IPO, The AI Divide In Venture Capital | Bloomberg Deals 4/1/2026

Bloomberg's weekly midday program will feature senior dealmakers — Bain Capital Managing Partner David Gross; Axiom Partners Founder Sandhya Venkatachalam; Salesforce Ventures Managing Partner Paul Drews; Westbridge Capital Principal Manthan Shah; and Morgan Stanley Global Co-Head of M&A Tom Miles. No specific transactions, figures, or guidance were reported; the segment provides access to senior PE/VC/M&A perspectives but is routine editorial coverage unlikely to move markets.

Analysis

A pick‑up in announced corporates transactions would be a clear net positive for bulge‑bracket advisory franchises and alternative asset managers that monetize exits, but the more actionable insight is the distributional impact: advisory fees are concentrated in a handful of mega‑deals, so a modest number of $10–50bn transactions can move a bank’s quarterly EPS by mid‑single digits. If M&A activity improves by ~20% year/year over the next 6–12 months, expect advisory revenue for the largest houses to expand 8–15% on a relative basis, amplifying FICC and ECM flows that follow deal rhythms.

Private markets dynamics will create second‑order winners. Pressure on late‑stage valuations and constrained IPO windows increases reliance on strategic and sponsored exits, which boosts placement and secondary market activity — a tailwind for private credit and GP-led managers who can offer liquidity solutions and capture 200–400bps higher yield vs syndicated markets. Conversely, corporates facing higher funding costs will structure more contingent consideration and earnouts, depressing near‑term cash valuations for targets and creating optionality for opportunistic buyers over 3–18 months.

Funding and liquidity remain the key constraint: a sudden 50–75bp widening in credit spreads or a renewed risk‑off episode can shut deal flow within weeks and reverse repricing gains, so time horizon matters. The underappreciated risk is competitive compression of fees — increased direct negotiations and secondary solutions can siphon traditional advisory share, muting the upside for banks even if headline deal counts rise.

Against consensus, the market is underpricing the asymmetry between fee capture and balance‑sheet exposure: big banks can win fees but also take mark risk on financing commitments. That argues for calibrated, event‑driven exposure rather than blunt sector bets.

Key Decisions for Investors

• Buy MS (Morgan Stanley) stock or a 6–12 month call spread (target 20–30% upside if M&A volumes rise); size as a tactical overweight (3–5% book) with stop‑loss at 12% downside — rationale: direct fee exposure to any sustained uplift in advisory and ECM activity.
• Go long alternative asset managers / private credit (e.g., ARES, BX, KKR) vs short regional bank ETF (KRE) — 6–12 month horizon. Risk/reward: alternatives capture 150–300bps yield differential and AUM growth if secondary/GP‑led volume rises; downside if credit stress widens sharply. Use 50/50 notional sizing to limit market beta.
• Purchase tail protection on deal‑sensitive names: buy 3‑month 5–10% OTM puts on MS or KRE to hedge a rapid spread‑widening event; cost should be <2–3% of position and protects against a quick collapse in deal flow.
• Event‑driven arbitrage: deploy capital for small, high‑conviction positions in public companies likely to be takeover targets (screen for >20% net cash plus under‑earning multiples) with 3–9 month timeframes. Target 2:1 reward to risk per position and keep position sizes idiosyncratic (1–2% book) to avoid market beta.